Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Human APP/Protease Nexin II (Research Grade Solanezumab Biosimilar) Alexa Fluor 750-conjugated Antibody, R&D Systems™

Human Monoclonal Antibody

Supplier:  R&D Systems FAB9919S100UG

Catalog No. FAB9919S-100


Due to product restrictions, please to purchase or view availability for this product.

This item is not returnable. View return policy

Description

Description

APP Monoclonal specifically detects APP in Human samples. It is validated for Flow Cytometry.
Specifications

Specifications

APP
Monoclonal
Alexa Fluor 750
Supplied 0.2Mg/mL in a saline solution containing BSA and Sodium Azide.
Human
Protein A or G purified from cell culture supernatant
Primary
Detects Human APP/Protease Nexin II based on Solanezumab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Solanezumab. This product is for research use only.
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 degreesC as supplied.
IgG1
Flow Cytometry
Hu13
Flow Cytometry 0.25-1μg/106 cells
Amyloid beta, amyloid beta (A4) precursor protein-binding, family B, member 2, amyloid beta A4 precursor protein-binding family B member 2, Amyloid beta precursor protein, APP, beta Amyloid, Protease Nexin II
Human APP/Protease Nexin II
100 μg
351
Human
Supernatant
Product Suggestions

Product Suggestions

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit